BiomarkerBay will be in Manchester, UK, on 21-22 February 2017.
The Biomarkers Congress brings together over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions to discuss on key innovations of biomarker research in discovery and development, companion diagnostics, data management, innovative biology, precision medicine and clinical biomarkers. For the full program, please visit the page here.
We will be present with Ymke van der Geld, Director Business Developer BiomarkerBay, and Ep Oosting, CTO of our partner Analytical Biochemical Laboratory (ABL).
